The Sahlgrenska Centre for Pediatric Ophthalmology Research, Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, University of Gothenburg Sahlgrenska Academy, Gothenburg, Sweden
Department of Clinical Neuroscience, Section for Eye and Vision, Karolinska Institutet, Stockholm, Sweden.
BMJ Open. 2022 Aug 3;12(8):e055567. doi: 10.1136/bmjopen-2021-055567.
To retrospectively evaluate ophthalmological and neurological outcomes in a Swedish cohort of infants born before 24 weeks gestational age (GA) and explore risk factors for visual impairment.
Eye and paediatric clinics in Sweden.
Infants screened for retinopathy of prematurity (ROP) (n=399), born before 24 weeks GA, 2007-2018. Cases were excluded if ophthalmological follow-up records could not be traced.
Primary outcomes were ophthalmological, including visual acuity (VA), refractive error, strabismus, nystagmus and cerebral visual impairment (CVI). Secondary outcomes comprised neonatal and neurological morbidities. Data were retrospectively retrieved from medical records.
The 355 assessed children had a median GA of 23 weeks and 2 days and a median birth weight of 565 g. At the last available ophthalmological examination, the median age was 4.8 years (range 0.5-13.2 years). Nystagmus was recorded in 21.1%, strabismus in 34.8%, and 51.0% wore spectacles. Seventy-three of 333 (21.9%) were visually impaired, defined as being referred to a low vision clinic and/or having a VA less than 20/60 at 3.5 years of age or older. ROP treatment was a significant risk factor for visual impairment (OR 2.244, p=0.003). Visually impaired children, compared with children without visual impairment, more often had neurological deficits such as intellectual disability 63.8% versus 33.3% (p<0.001), epilepsy 21.1% versus 7.5% (p=0.001) and autism spectrum disorders 32.8% versus 20.9% (p=0.043). Nine of the 355 children had been diagnosed with CVI.
Children born before 24 weeks GA frequently had visual impairment in association with neurological deficits. CVI was rarely diagnosed. A multidisciplinary approach for the evaluation and habilitation of these vulnerable infants is warranted. National follow-up guidelines need to be developed and implemented.
回顾性评估瑞典 24 周以下胎龄(GA)早产儿队列的眼科和神经学结局,并探讨视力障碍的危险因素。
瑞典的眼科和儿科诊所。
2007 年至 2018 年筛查早产儿视网膜病变(ROP)(n=399)的 24 周以下 GA 出生婴儿。如果无法追踪到眼科随访记录,则排除病例。
主要结局为眼科结局,包括视力(VA)、屈光不正、斜视、眼球震颤和脑性视觉障碍(CVI)。次要结局包括新生儿和神经发育不良。数据从病历中回顾性检索。
355 名评估儿童的中位 GA 为 23 周 2 天,中位出生体重为 565g。在最后一次可获得的眼科检查时,中位年龄为 4.8 岁(范围 0.5-13.2 岁)。记录到眼球震颤 21.1%,斜视 34.8%,51.0%戴眼镜。333 名中有 73 名(21.9%)视力受损,定义为转诊至低视力诊所和/或 3.5 岁及以上时 VA 小于 20/60。ROP 治疗是视力障碍的显著危险因素(OR 2.244,p=0.003)。与无视力障碍的儿童相比,视力受损的儿童更常伴有神经发育不良,如智力残疾 63.8%对 33.3%(p<0.001),癫痫 21.1%对 7.5%(p=0.001)和自闭症谱系障碍 32.8%对 20.9%(p=0.043)。355 名儿童中有 9 名被诊断为 CVI。
24 周 GA 以下出生的儿童常伴有与神经发育不良相关的视力障碍。很少诊断出 CVI。需要为这些脆弱婴儿提供多学科评估和康复。需要制定和实施国家随访指南。